22634505|t|Theaflavin ameliorates behavioral deficits, biochemical indices and monoamine transporters expression against subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson's disease.
22634505|a|Evidence from clinical and experimental studies indicates that degeneration of nigrostriatal dopaminergic neurons is a pathological hallmark of Parkinson's disease (PD). The present study was designed to investigate the neuroprotective potential of theaflavin (TF) on oxidative stress, monoamine transporters and behavioral abnormalities in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurodegeneration. TF, a black tea polyphenol, has been known to possess neuroprotective effects against ischemia, Alzheimer's disease and other neurodegenerative disorders, but the mechanisms underlying its beneficial effects on MPTP-induced dopaminergic neurodegeneration are poorly defined. Administration of MPTP (30 mg/kg bw for four consecutive days) led to increased oxidative stress and reduced behavior patterns (open field, rotarod and hang test), nigrostriatal dopamine transporter (DAT) (immunohistochemistry and Western blot) and vesicular monoamine transporter 2 (VMAT2) (Western blot) expressions. Pre-treatment with TF reduces oxidative stress, improves motor behavior and expression of DAT and VMAT2 in striatum and substantia nigra. These results indicate that TF might be beneficial in mitigating MPTP-induced damage of dopaminergic neurons, possibly via its neuroprotective and its antioxidant potential.
22634505	0	10	Theaflavin	Chemical	MESH:C056068
22634505	23	42	behavioral deficits	Disease	MESH:D019958
22634505	119	163	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Chemical	MESH:D015632
22634505	165	169	MPTP	Chemical	MESH:D015632
22634505	179	184	mouse	Species	10090
22634505	194	213	Parkinson's disease	Disease	MESH:D010300
22634505	359	378	Parkinson's disease	Disease	MESH:D010300
22634505	380	382	PD	Disease	MESH:D010300
22634505	464	474	theaflavin	Chemical	MESH:C056068
22634505	476	478	TF	Chemical	MESH:C056068
22634505	528	552	behavioral abnormalities	Disease	MESH:D001523
22634505	556	600	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Chemical	MESH:D015632
22634505	602	606	MPTP	Chemical	MESH:D015632
22634505	616	633	neurodegeneration	Disease	MESH:D019636
22634505	635	637	TF	Chemical	MESH:C056068
22634505	651	661	polyphenol	Chemical	MESH:D059808
22634505	721	729	ischemia	Disease	MESH:D007511
22634505	731	750	Alzheimer's disease	Disease	MESH:D000544
22634505	761	788	neurodegenerative disorders	Disease	MESH:D019636
22634505	846	850	MPTP	Chemical	MESH:D015632
22634505	872	889	neurodegeneration	Disease	MESH:D019636
22634505	928	932	MPTP	Chemical	MESH:D015632
22634505	1088	1108	dopamine transporter	Gene	13162
22634505	1110	1113	DAT	Gene	13162
22634505	1159	1192	vesicular monoamine transporter 2	Gene	214084
22634505	1194	1199	VMAT2	Gene	214084
22634505	1248	1250	TF	Chemical	MESH:C056068
22634505	1319	1322	DAT	Gene	13162
22634505	1327	1332	VMAT2	Gene	214084
22634505	1395	1397	TF	Chemical	MESH:C056068
22634505	1432	1436	MPTP	Chemical	MESH:D015632
22634505	1445	1475	damage of dopaminergic neurons	Disease	MESH:D009422
22634505	Negative_Correlation	MESH:C056068	13162
22634505	Negative_Correlation	MESH:C056068	MESH:D019958
22634505	Negative_Correlation	MESH:C056068	MESH:D009422
22634505	Negative_Correlation	MESH:C056068	MESH:D007511
22634505	Negative_Correlation	MESH:C056068	MESH:D001523
22634505	Negative_Correlation	MESH:D015632	13162
22634505	Positive_Correlation	MESH:D015632	MESH:D009422
22634505	Negative_Correlation	MESH:D015632	214084
22634505	Negative_Correlation	MESH:C056068	MESH:D019636
22634505	Negative_Correlation	MESH:D015632	MESH:D010300
22634505	Positive_Correlation	MESH:C056068	214084
22634505	Negative_Correlation	MESH:C056068	MESH:D000544
22634505	Positive_Correlation	MESH:D015632	MESH:D019636
22634505	Negative_Correlation	MESH:C056068	MESH:D015632

